Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 17, 2023

BUY
$6.87 - $10.96 $158,958 - $253,592
23,138 New
23,138 $0
Q1 2022

Apr 11, 2022

BUY
$10.84 - $16.55 $5,116 - $7,811
472 Added 2.14%
22,535 $255,000
Q4 2021

Feb 09, 2022

BUY
$15.69 - $21.14 $3,859 - $5,200
246 Added 1.13%
22,063 $346,000
Q3 2021

Oct 29, 2021

BUY
$15.35 - $21.27 $334,890 - $464,047
21,817 New
21,817 $382,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $271M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Maryland State Retirement & Pension System Portfolio

Follow Maryland State Retirement & Pension System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland State Retirement & Pension System, based on Form 13F filings with the SEC.

News

Stay updated on Maryland State Retirement & Pension System with notifications on news.